Coca-Cola Company (KO) 40.84 $KO Coke Vs. Pepsi: Which

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Coca-Cola Company (KO) 40.84 $KO

Coke Vs. Pepsi: Which Stock Tastes Better?
at Investor's Business Daily - 36 mins ago
In the spirit of the Pepsi Challenge, we'll take a look at Coca-Cola (KO) and PepsiCo's (PEP) earnings, fundamentals and stock price action. Atlanta-based Coca-Cola on Wednesday topped views with a 2% slip in Q2 comparable earnings to 63 cents on a...
KO: 40.84 (-0.06), MNST: 148.53 (+0.68), PEP: 96.87 (-0.30)

Dr Pepper (DPS) Beats Q2 Earnings, Sales In Line; Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 23, 12:00PM CDT
Dr Pepper Snapple Group Inc. (DPS) reported mixed second-quarter 2015 results, beating the Zacks Consensus Estimate for earnings while delivering in-line revenues.
DPS: 77.26 (-1.46), KO: 40.84 (-0.06), MNST: 148.53 (+0.68), PEP: 96.87 (-0.30)

Old-Fashioned Food Companies Are Finally Getting Their Mojo Back
at The Street - Thu Jul 23, 9:00AM CDT
Ingredient makeovers and retailer resets are breathing new life into these classic names.
KO: 40.84 (-0.06), HAIN: 68.11 (+0.08), HSY: 90.65 (-0.44), TGT: 81.65 (-1.17), WMT: 72.51 (-0.65), CPB: 48.20 (-0.12), GIS: 57.08 (-0.55), K: 64.33 (-0.06)

MCC Senior Official Brings Development Opportunities to Atlanta Businesses
M2 - Thu Jul 23, 4:45AM CDT
Washington, D.C.- Millennium Challenge Corporation Chief Financial Officer Matt Bohn met with U.S. businesses and civic and international development leaders this week in Atlanta to discuss opportunities for expansion into new and emerging markets. His visit was part of MCC an agency-wide effort to bring development and partnership opportunities to U.S. businesses across the country.
KO: 40.84 (-0.06)

Sony Pays Pretty Penny for Latest Bond, 'Spectre'
at The Street - Wed Jul 22, 6:59PM CDT
The studio spends $350 million for the 24th installment of the James Bond series, including the costs of Astin Martin and Jaguar cars and the Omega watch.
KO: 40.84 (-0.06), F: 14.61 (+0.19), SNE: 29.20 (+0.82)

Coke tops, Diet Coke sinks
at Investor's Business Daily - Wed Jul 22, 5:49PM CDT
Coca-Cola (KO) fizzed past views as comparable earnings fell a penny from '14 to 63 cents, above views by 3 cents. The beverage giant said that gains related to closing its Monster Beverage (MNST) stake helped reported EPS of 71 cents. Revenue fell...
KO: 40.84 (-0.06), MNST: 148.53 (+0.68)

Coca-Cola Company Earnings: Investors Get More of the Same
Rich Duprey, The Motley Fool - Motley Fool - Wed Jul 22, 5:20PM CDT
Coca-Cola surprised Wall Street as price hikes continue to pay dividends. If Coca-Cola 's second-quarter earnings report from Wednesday morning sounds familiar, it's probably because the increased profits on lower revenue was the same tune it...
KO: 40.84 (-0.06)

Could Monster Beverage Corp. Energize Your Portfolio with Profits? - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Wed Jul 22, 2:22PM CDT
Monster Beverage Corporation is poised for success in the near future, and investors should be seriously considering the company's stock for investment.
KO: 40.84 (-0.06), MNST: 148.53 (+0.68), PEP: 96.87 (-0.30)

Coca-Cola (KO) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Wed Jul 22, 1:41PM CDT
The following Coca-Cola (KO) conference call took place on July 22, 2015, 09:30 AM ET. This is a transcript of that earnings call:
KO: 40.84 (-0.06)

How to Trade 5 of the Market's Most Active Stocks
at The Street - Wed Jul 22, 1:40PM CDT
Here's a technical look at how to trade some of the highest-volume stocks on the market today.
KO: 40.84 (-0.06), XOM: 81.14 (-0.65), ILMN: 219.94 (+2.45), TSM: 22.31 (+0.09), MSFT: 46.11 (+0.57)

Coke Cuts Costs, Raises Prices to Offset Sluggish Soda Sales
at The Street - Wed Jul 22, 12:39PM CDT
The company's second-quarter earnings beat estimates, but fell from a year earlier.
KO: 40.84 (-0.06), JBLU: 23.22 (-0.30)

Coca-Cola Flexes Its Pricing Muscle
Asit Sharma, The Motley Fool - Motley Fool - Wed Jul 22, 12:31PM CDT
Image courtesy flickr user "Wrote" under Creative Commons license. The Coca-Cola Company  on Wednesday reported a quarterly decline in revenue due to foreign currency pressures, but higher net income on a gain from its recently concluded...
KO: 40.84 (-0.06)

Coca-Cola's Solid Quarter Drives Hope for Turnaround
at The Street - Wed Jul 22, 12:07PM CDT
New packaging and the performance of its non-carbonated drink lines helped the beverage giant post better-than-expected quarterly results.
KO: 40.84 (-0.06), PEP: 96.87 (-0.30)


Coca-Cola fetching higher prices with marketing, mini-cans
By CANDICE CHOI - AP - Wed Jul 22, 12:02PM CDT
NEW YORK (AP) — Coca-Cola says people are shelling out more money for its drinks, thanks to a mix of reinvigorated marketing and mini-cans and glass bottles that tend to cost more.
KO: 40.84 (-0.06), SBUX: 56.56 (-0.13), MNST: 148.53 (+0.68), PEP: 96.87 (-0.30)

Earnings Highlights for July 22nd: KO Beats, QCOM to Miss? - Stocks in the News
Eric Dutram - Zacks Investment Research - Wed Jul 22, 11:39AM CDT
Boeing, Coca Cola, and Abbott highlight the list of companies that have reported earnings. Qualcomm, Hanesbrands, and American Express are due up after the bell.
KO: 40.84 (-0.06), ABT: 51.20 (+0.22), AXP: 77.01 (-1.98), QCOM: 61.78 (-2.41), HBI: 34.00 (-0.33), BA: 146.11 (-0.36)

Coca-Cola Fizzes Past Views Even As Diet Coke Sinks
at Investor's Business Daily - Wed Jul 22, 10:28AM CDT
Coca-Cola (KO) bubbled past Wall Street views Wednesday as the beverage giant hiked drink prices. Demand for Diet Coke continued to decline. Comparable earnings dipped a little less than 2% to 63 cents, 3 cents over consensus estimates. Coke reported...
DPS: 77.26 (-1.46), KO: 40.84 (-0.06), MNST: 148.53 (+0.68), PEP: 96.87 (-0.30)

Stocks Fall Back as Crude Oil Dips Below $50
at The Street - Wed Jul 22, 9:53AM CDT
Stocks return to near session lows on Wednesday morning as crude oil dips below $50 a barrel on the back of a rise in weekly inventories.
KO: 40.84 (-0.06), GPRO: 63.95 (+2.27), BA: 146.11 (-0.36), T: 33.93 (-0.34), YHOO: 39.21 (-0.03), CMG: 725.94 (+0.12), DTV: 92.19 (-0.64), STJ: 75.53 (-1.14), THOR: 63.06 (-0.40), MSFT: 46.11 (+0.57), AAPL: 125.16 (-0.06)

Coca-Cola (KO) Beats Q2 Earnings & Sales; US Volumes Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 22, 9:27AM CDT
The Coca-Cola Company (KO) beat the Zacks Consensus Estimate for both earnings and revenues in the second quarter.
KO: 40.84 (-0.06), MNST: 148.53 (+0.68), GMCR: 71.32 (-0.60), PEP: 96.87 (-0.30)

Minus Apple, Tech Sector Q2 Earnings Soft - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Wed Jul 22, 9:22AM CDT
Despite a strong contribution from Apple, we've seen weak performances from Tech sector companies relative to what we have been seeing in recent quarters.
KO: 40.84 (-0.06), WHR: 179.43 (+1.07), GOOGL: 674.73 (-20.37), BA: 146.11 (-0.36), AAPL: 125.16 (-0.06)

Coca-Cola (KO) Stock Rises on Earnings Beat
at The Street - Wed Jul 22, 8:47AM CDT
Shares of Coca-Cola (KO) are trading higher after the company reported better-than-expected earnings results for the second quarter of 2015.
KO: 40.84 (-0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading